BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28076676)

  • 1. Use of Metformin for Cardiometabolic Risks in Psychiatric Practice: Need-to-Know Safety Issues.
    Andrade C
    J Clin Psychiatry; 2016 Nov; 77(11):e1491-e1494. PubMed ID: 28076676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and mental illness. Weight gain and other unhealthy attributes increase risk of diabetes and heart disease.
    Harv Ment Health Lett; 2011 Aug; 28(2):5. PubMed ID: 21980633
    [No Abstract]   [Full Text] [Related]  

  • 3. Metformin as a Possible Intervention for Cardiometabolic Risks in Pediatric Subjects Exposed to Antipsychotic Drugs.
    Andrade C
    J Clin Psychiatry; 2016 Oct; 77(10):1362-1364. PubMed ID: 27788311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaining: pediatric patients and use of atypical antipsychotics.
    Towbin KE
    Am J Psychiatry; 2006 Dec; 163(12):2034-6. PubMed ID: 17151148
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Ellinger LK; Ipema HJ; Stachnik JM
    Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin-'BRAINS & AIMS' pharmacological/prescribing principles of commonly prescribed (Top 100) drugs: Education and discussion.
    Koslover J; Bruce D; Patel S; Webb AJ
    Br J Clin Pharmacol; 2023 Mar; 89(3):931-938. PubMed ID: 36575901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
    Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
    Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
    Miller LJ
    Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adverse effect of biguanides].
    Yamasaki Y; Kuroda A
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():389-92. PubMed ID: 12387023
    [No Abstract]   [Full Text] [Related]  

  • 10. Metformin for non-insulin-dependent diabetes mellitus.
    Med Lett Drugs Ther; 1995 May; 37(948):41-2. PubMed ID: 7739421
    [No Abstract]   [Full Text] [Related]  

  • 11. Metformin-associated lactic acidosis: Current perspectives on causes and risk.
    DeFronzo R; Fleming GA; Chen K; Bicsak TA
    Metabolism; 2016 Feb; 65(2):20-9. PubMed ID: 26773926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A "glucose eater" drug as a therapeutic agent in psychiatry.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2013 Sep; 51(9):13-6. PubMed ID: 23938069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome with the atypical antipsychotics.
    Pramyothin P; Khaodhiar L
    Curr Opin Endocrinol Diabetes Obes; 2010 Oct; 17(5):460-6. PubMed ID: 20717020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Severe lactic acidosis due to metformin: report of 3 cases].
    Roche C; Nau A; Peytel E; Moalic JL; Oliver M
    Ann Biol Clin (Paris); 2011; 69(6):705-11. PubMed ID: 22123572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactic acidosis induced by metformin in a chronic hemodialysis patient with diabetes mellitus type 2.
    Altun E; Kaya B; Paydaş S; Sarıakçalı B; Karayaylalı I
    Hemodial Int; 2014 Apr; 18(2):529-31. PubMed ID: 24299454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do risk factors for lactic acidosis influence dosing of metformin?
    Millican S; Cottrell N; Green B
    J Clin Pharm Ther; 2004 Oct; 29(5):449-54. PubMed ID: 15482389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin in patients with chronic kidney disease: strengths and weaknesses.
    Rocha A; Almeida M; Santos J; Carvalho A
    J Nephrol; 2013; 26(1):55-60. PubMed ID: 22641582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactic acidosis. Lactic acidosis associated with metformin use in treatment of type 2 diabetes mellitus.
    DePalo VA; Mailer K; Yoburn D; Crausman RS
    Geriatrics; 2005 Nov; 60(11):36, 39-41. PubMed ID: 16287340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin: preventable lactic acidosis.
    Prescrire Int; 2007 Feb; 16(87):19. PubMed ID: 17323526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term use of metformin leading to vitamin B 12 deficiency.
    Tung ML; Tan LK
    Diabetes Res Clin Pract; 2014 Jun; 104(3):e75-6. PubMed ID: 24674102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.